Brief: Shanghai Haohai Biological Technology Co Posts HY Profit Attributable Rmb182.57 Mln
Aug 2 (Reuters) - Shanghai Haohai Biological Technology Co
Ltd 6826.HK :
* HY REVENUE RMB780.6 MILLION VERSUS RMB761.1 MILLION
* HY PROFIT ATTRIBUTABLE RMB182.57 MILLION, DOWN 13.7%
Source text for Eikon: ID:nHKS4Vpw01
Further company coverage: 6826.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.